Optimisation and evaluation of the random forest model in the efficacy prediction of chemoradiotherapy for advanced cervical cancer based on radiomics signature from high-resolution T2 weighted images
-
Published:2021-01-04
Issue:3
Volume:303
Page:811-820
-
ISSN:0932-0067
-
Container-title:Archives of Gynecology and Obstetrics
-
language:en
-
Short-container-title:Arch Gynecol Obstet
Author:
Liu Defeng, Zhang Xiaohang, Zheng Tao, Shi Qinglei, Cui Yujie, Wang Yongji, Liu LanxiangORCID
Abstract
Abstract
Purpose
Our objective was to establish a random forest model and to evaluate its predictive capability of the treatment effect of neoadjuvant chemotherapy–radiation therapy.
Methods
This retrospective study included 82 patients with locally advanced cervical cancer who underwent scanning from March 2013 to May 2018. The random forest model was established and optimised based on the open source toolkit scikit-learn. Byoptimising of the number of decision trees in the random forest, the criteria for selecting the final partition index and the minimum number of samples partitioned by each node, the performance of random forest in the prediction of the treatment effect of neoadjuvant chemotherapy–radiation therapy on advanced cervical cancer (> IIb) was evaluated.
Results
The number of decision trees in the random forests influenced the model performance. When the number of decision trees was set to 10, 25, 40, 55, 70, 85 and 100, the performance of random forest model exhibited an increasing trend first and then a decreasing one. The criteria for the selection of final partition index showed significant effects on the generation of decision trees. The Gini index demonstrated a better effect compared with information gain index. The area under the receiver operating curve for Gini index attained a value of 0.917.
Conclusion
The random forest model showed potential in predicting the treatment effect of neoadjuvant chemotherapy–radiation therapy based on high-resolution T2WIs for advanced cervical cancer (> IIb).
Funder
National Key Research and development program of the Ministry of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference40 articles.
1. Chan DSM, Abar L, Cariolou M, Nanu N, Greenwood DC, Bandera EV, McTiernan A, Norat T (2019) World Cancer Research Fund International: continuous update project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes Control 30:1183–1200 2. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA cancer J Clin 65:5–29 3. Vitale SG, Capriglione S, Zito G, Lopez S, Gulino FA, Di Guardo F, Vitagliano A, Noventa M, La Rosa VL, Sapia F, Valenti G, Rapisarda AMC, Peterlunger I, Rossetti D, Laganà AS (2019) Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition. Arch Gynecol Obstet 299:299–315 4. Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu HS, Ngan H, Mäenpää J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstetr Off Organ Int Feder Gynaecol Obstetr 145:129–135 5. Rongsriyam K, Tangjitgamol S, Leelahavarong P, Teerawattananon Y, Tharavichitkul E, Tovanabutra C, Asakij T, Paengchit K, Sukhaboon J, Penpattanagul S, Kridakara LCA, Hanprasertpong J, Khunnarong J, Chottetanaprasith T, Lorvidhaya V (2020) Cost-utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer. J Med Imag Radiat Oncol. https://doi.org/10.1111/1754-9485.13103
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|